Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT02643550 · COMPLETED
Trial details
- NCT number
- NCT02643550
- Sponsor
- Innate Pharma
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2023-03-28
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.